terfenadine has been researched along with Atrophy in 1 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Excerpt | Relevance | Reference |
---|---|---|
"To evaluate whether 1 year of continuous treatment with intranasal fluticasone propionate would lead to atrophy in the nasal mucosa compared with an active control, oral terfenadine." | 9.09 | Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. ( Baroody, FM; Cheng, CC; Cook, CK; Corey, JP; deTineo, M; Haney, L; Moylan, B; Naclerio, RM; Reed, KD; Sengupta, E; Togias, A; Westlund, RE, 2001) |
"To evaluate whether 1 year of continuous treatment with intranasal fluticasone propionate would lead to atrophy in the nasal mucosa compared with an active control, oral terfenadine." | 5.09 | Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. ( Baroody, FM; Cheng, CC; Cook, CK; Corey, JP; deTineo, M; Haney, L; Moylan, B; Naclerio, RM; Reed, KD; Sengupta, E; Togias, A; Westlund, RE, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baroody, FM | 1 |
Cheng, CC | 1 |
Moylan, B | 1 |
deTineo, M | 1 |
Haney, L | 1 |
Reed, KD | 1 |
Cook, CK | 1 |
Westlund, RE | 1 |
Sengupta, E | 1 |
Corey, JP | 1 |
Togias, A | 1 |
Naclerio, RM | 1 |
1 trial available for terfenadine and Atrophy
Article | Year |
---|---|
Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray.
Topics: Administration, Intranasal; Administration, Oral; Adult; Androstadienes; Anti-Allergic Agents; Anti- | 2001 |